Revised Outcome of Board Meeting held on July 24, 2025
IGCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indogulf Cropsciences filed the revised outcome of its board meeting held on July 24, 2025, at which directors approved the audited standalone and consolidated financial results for the financial year ended March 31, 2025. Statutory auditor Devesh Parekh & Co. issued an unmodified (clean) opinion on both sets of results, and the CFO separately filed a declaration confirming the unmodified opinion under SEBI LODR Regulation 33(3)(d). Consolidated revenue from operations for FY25 stood at Rs 5,904.21 million, while consolidated profit after tax grew to about Rs 347.2 million from Rs 282.33 million in FY24, roughly a 23% rise. Standalone PAT also showed strong growth year-on-year. The company operates a single agro-chemicals segment and recently listed on BSE and NSE on July 3, 2025, after allotting 14.44 lakh fresh equity shares through a public issue at a Rs 101 premium.
A clean audit opinion and healthy double-digit profit growth are reassuring for a newly-listed stock, and this filing represents one of the first financial disclosures post-listing. Investors will watch closely to see how the IPO proceeds are deployed and whether the FY25 growth momentum carries into FY26.